Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. (ADXS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ADXS · as of Jun 15, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
3
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Ayala Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 15, 2026
ADXS insider buying and selling by quarter
ADXS insider selling · ADXS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 15, 2026
Recent insider transactions
ADXS executive sell shares · ADXS board member insider trading · ADXS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 19, 2023 | SIDRANSKY DAVID Director | Award | 46 | — | Form 4 |
| Mar 11, 2020 | APPEL RONI Director | Sale | 399 | $267 | Form 4 |
| Mar 12, 2020 | APPEL RONI Director | Sale | 200 | $116 | Form 4 |
| Mar 13, 2020 | APPEL RONI Director | Sale | 2,401 | $1K | Form 4 |
| Apr 11, 2019 | Gutierrez Andres Executive Vice President & CMO | Award | 3,750 | $14K | Form 4 |
| Apr 10, 2019 | APPEL RONI Director | Purchase | 3,000 | $11K | Form 4 |
| Apr 11, 2019 | Henderson Molly Executive Vice President & CFO | Award | 2,500 | $9K | Form 4 |
| Apr 9, 2019 | Henderson Molly Executive Vice President & CFO | Award | 2,900 | $11K | Form 4 |
| Apr 9, 2019 | Henderson Molly Executive Vice President & CFO | Award | 100 | $385 | Form 4 |
| Apr 8, 2019 | Berlin Kenneth A President & CEO · Director | Award | 2,100 | $8K | Form 4 |
| Apr 8, 2019 | Berlin Kenneth A President & CEO · Director | Award | 1,100 | $4K | Form 4 |
| Apr 8, 2019 | Berlin Kenneth A President & CEO · Director | Award | 800 | $3K | Form 4 |
| Nov 5, 2018 | PETIT ROBERT Chief Scientific Officer | Sale | 3,963 | $2K | Form 4 |
| Nov 2, 2018 | PETIT ROBERT Chief Scientific Officer | Sale | 8,491 | $5K | Form 4 |
| Sep 11, 2018 | APPEL RONI Director | Purchase | 33,333 | $40K | Form 4 |
Gutierrez Andres
Executive Vice President & CMO
Date
Apr 11
Shares
3,750
Price
$3.71
Value
$14K
Henderson Molly
Executive Vice President & CFO
Date
Apr 11
Shares
2,500
Price
$3.68
Value
$9K
Henderson Molly
Executive Vice President & CFO
Date
Apr 9
Shares
2,900
Price
$3.86
Value
$11K
Henderson Molly
Executive Vice President & CFO
Date
Apr 9
Shares
100
Price
$3.85
Value
$385
Berlin Kenneth A
President & CEO · Director
Date
Apr 8
Shares
2,100
Price
$3.78
Value
$8K
Berlin Kenneth A
President & CEO · Director
Date
Apr 8
Shares
1,100
Price
$3.77
Value
$4K
Berlin Kenneth A
President & CEO · Director
Date
Apr 8
Shares
800
Price
$3.78
Value
$3K
PETIT ROBERT
Chief Scientific Officer
Date
Nov 5
Shares
3,963
Price
$0.58
Value
$2K
PETIT ROBERT
Chief Scientific Officer
Date
Nov 2
Shares
8,491
Price
$0.56
Value
$5K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ADXS insider trading
ADXS insider trades
Ayala Pharmaceuticals, Inc. (ADXS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ADXS. Over the past 12 months, 0 insiders have filed transactions with the SEC. ADXS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ayala Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ADXS insider trading · 5 questionsThe insiders of Ayala Pharmaceuticals, Inc. (ADXS) include executives and directors such as ADXS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 15, 2026